In vitro effects of GSM modulated radiofrequency fields on human immune cells

✍ Scribed by Helga Tuschl; Waltraud Novak; Hamid Molla-Djafari

• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 293 KB
• Volume: 27
• Category: Article
• ISSN: 0197-8462
• DOI: 10.1002/bem.20191

✦ Synopsis

Abstract

Despite the important role of the immune system in defending the body against infections and cancer, only few investigations on possible effects of radiofrequency (RF) radiation on function of human immune cells have been undertaken. Aim of the present investigation was therefore to assess whether GSM modulated RF fields have adverse effects on the functional competence of human immune cells. Within the frame of the multidisciplinary project “Biological effects of high frequency electromagnetic fields (EMF)” sponsored by the National Occupation Hazard Insurance Association (AUVA) in vitro investigations were carried out on human blood cells. Exposure was performed at GSM Basic 1950 MHz, an SAR of 1 mW/g in an intermittent mode (5 min “ON”, 10 min “OFF”) and a maximum Δ T of 0.06 °C for the duration of 8 h. The following immune parameters were evaluated: (1) the intracellular production of interleukin‐2 (IL‐2) and interferon (INF) gamma in lymphocytes, and IL‐1 and tumor necrosis factor (TNF)‐α in monocytes were evaluated with monoclonal antibodies. (2) The activity of immune‐relevant genes (IL 1‐α and β, IL‐2, IL‐2‐receptor, IL‐4, macrophage colony stimulating factor (MCSF)‐receptor, TNF‐α, TNF‐α‐receptor) and housekeeping genes was analyzed with real time PCR. (3) The cytotoxicity of lymphokine activated killer cells (LAK cells) against a tumor cell line was determined in a flow cytometric test. For each parameter, blood samples of at least 15 donors were evaluated. No statistically significant effects of exposure were found and there is no indication that emissions from mobile phones are associated with adverse effects on the human immune system. Bioelectromagnetics 27:188–196, 2006. © 2005 Wiley‐Liss, Inc.